本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Mersana Therapeutics Inc.

27.83
-0.0900-0.32%
成交量:10.35萬
成交額:287.17萬
市值:1.39億
市盈率:-1.86
高:28.05
開:27.60
低:27.54
收:27.92
52周最高:70.73
52周最低:5.21
股本:499.88萬
流通股本:375.34萬
量比:0.23
換手率:2.76%
股息:- -
股息率:- -
每股收益(TTM):-14.9441
每股收益(LYR):-14.1163
淨資產收益率:-505.14%
總資產收益率:-34.11%
市淨率:-2.62
市盈率(LYR):-1.97

資料載入中...

2025/01/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/14

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/01/10

重要事件披露

Form 8-K - Current report
2025/01/10

重要事件披露

Form 8-K - Current report
2024/12/19

重要事件披露

Form 8-K - Current report
2024/11/15

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/11/15

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/13

重要事件披露

Form 8-K - Current report
2024/10/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/15

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/10/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities